Search Results - "Fromm Longo, Jody"
-
1
LPAR1 and aberrantly expressed LPAR3 differentially promote the migration and proliferation of malignant peripheral nerve sheath tumor cells
Published in Glia (01-03-2023)“…Schwann cell‐derived neoplasms known as malignant peripheral nerve sheath tumors (MPNSTs) are the most common malignancy and the leading cause of death in…”
Get full text
Journal Article -
2
Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models
Published in Journal of visualized experiments (17-05-2024)“…Patients with the autosomal dominant tumor susceptibility syndrome neurofibromatosis type 1 (NF1) commonly develop plexiform neurofibromas (PNs) that…”
Get more information
Journal Article -
3
Establishment and genomic characterization of a sporadic malignant peripheral nerve sheath tumor cell line
Published in Scientific reports (11-03-2021)“…Malignant peripheral nerve sheath tumors (MPNSTs) are aggressive Schwann cell-derived neoplasms that occur sporadically or in patients with neurofibromatosis…”
Get full text
Journal Article -
4
R-Ras subfamily proteins elicit distinct physiologic effects and phosphoproteome alterations in neurofibromin-null MPNST cells
Published in Cell communication and signaling (16-09-2021)“…Loss of the Ras GTPase-activating protein neurofibromin promotes nervous system tumor pathogenesis in patients with neurofibromatosis type 1 (NF1)…”
Get full text
Journal Article -
5
ErbB4 promotes malignant peripheral nerve sheath tumor pathogenesis via Ras-independent mechanisms
Published in Cell communication and signaling (10-07-2019)“…We have found that erbB receptor tyrosine kinases drive Ras hyperactivation and growth in NF1-null malignant peripheral nerve sheath tumors (MPNSTs). However,…”
Get full text
Journal Article -
6
Salinomycin targets the genome of radioresistant cells in glioblastomas
Published in Neuro-oncology (Charlottesville, Va.) (20-02-2020)Get full text
Journal Article -
7
The RASopathies: Biology, genetics and therapeutic options
Published in Advances in cancer research (2022)“…The RASopathies are a group of genetic diseases in which the Ras/MAPK signaling pathway is inappropriately activated as a result of mutations in genes encoding…”
Get full text
Journal Article -
8
Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor
Published in Journal of visualized experiments (25-08-2023)“…Malignant Peripheral Nerve Sheath Tumors (MPNSTs) are derived from Schwann cells or their precursors. In patients with the tumor susceptibility syndrome…”
Get more information
Journal Article -
9
Recent Advances in the Diagnosis and Pathogenesis of Neurofibromatosis Type 1 (NF1)-associated Peripheral Nervous System Neoplasms
Published in Advances in anatomic pathology (01-09-2018)“…The diagnosis of a neurofibroma or a malignant peripheral nerve sheath tumor (MPNST) often raises the question of whether the patient has the genetic disorder…”
Get full text
Journal Article -
10
Combinatorial Therapy With Tamoxifen and Trifluoperazine Effectively Inhibits Malignant Peripheral Nerve Sheath Tumor Growth by Targeting Complementary Signaling Cascades
Published in Journal of neuropathology and experimental neurology (01-11-2014)“…ABSTRACTChemotherapeutic agents effective against malignant peripheral nerve sheath tumors (MPNSTs) are urgently needed. We recently found that tamoxifen…”
Get full text
Journal Article -
11
Classic Ras Proteins Promote Proliferation and Survival via Distinct Phosphoproteome Alterations in Neurofibromin-Null Malignant Peripheral Nerve Sheath Tumor Cells
Published in Journal of neuropathology and experimental neurology (01-06-2015)“…Neurofibromin, the tumor suppressor encoded by the neurofibromatosis type 1 (NF1) gene, potentially suppresses the activation of H-Ras, N-Ras, and K-Ras…”
Get full text
Journal Article